Skip to main content
OpenTrials

Clinical trial condition

Lymphoplasmacytic Lymphoma

Explore clinical trials studying Lymphoplasmacytic Lymphoma. Study availability and eligibility vary by location and protocol.

46 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Lymphoplasmacytic Lymphoma trial results

Recruiting

Study of SGR-1505 in Mature B-Cell Neoplasms

NCT05544019

Conditions
ALK-Positive Large B-Cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +66 more
Locations
  • Banner Health - MD Anderson Cancer Center Gilbert, Arizona, United States
  • Christiana Care Hospital - Helen F Graham Cancer Center Newark, Delaware, United States
  • Napa Research Pompano Beach, Florida, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 36 locations
View Trial Details
Enrolling by invitation

Watch and Wait or Worry and Wait in Indolent Lymphoma

NCT07173790

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
Locations
  • Samsung Medical Center Seoul, Gangnam-gu, South Korea
  • Korea UniversityKorea University Guro Hospital Seoul, Guro-gu, South Korea
  • Seoul National University Hospital Seoul, Jongno-gu, South Korea
  • The Catholic University of Korea Seoul, Seocho-gu, South Korea
View Trial Details
Active, not recruiting

Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

NCT07387471

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations
  • Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital /ID# 279178 Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital /ID# 277580 Nagoya, Aichi-ken, Japan
  • University of Fukui Hospital /ID# 279173 Yoshida-gun, Fukui, Japan
  • Kyushu University Hospital /ID# 277582 Fukuoka, Japan
View all 17 locations
View Trial Details
Active, not recruiting

Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma

NCT04799275

Conditions
Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IIX (Bulky) Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma, +30 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 176 locations
View Trial Details

Related conditions